# Pregene Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pregene-biotechnology

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.pregene.net
- Total disclosed funding: $16M
- Latest round: Series A (Jan 10, 2022)
- Investors on record: 2

## About

Based in Nanjing, China, and established in 2019, Pregene Biotechnology is a medical equipment company that business scope includes R&D, production, and sales of a new generation of molecular diagnostic kits and supporting instruments. The company has additional offices in Beijing, and Shanghai. 

The company provides molecular diagnostic kits and supporting instruments, taking the self-developed technologies of polymerase chain reaction (PCR) technology, droplet generation technology, nucleic acid extraction technology, and single-cell sequencing technology. The PCR technology and droplet digital PCR instruments can realize clinical application to screen tumor, pre-pregnancy, and infectious disease. 

The company plans to continue to R&D technologies, registration of products, and commercialization of products.

## Funding rounds

- Series A, Jan 10, 2022, $16M — Vertex Ventures China, Shijie Investment

## Investors

- Vertex Ventures China (https://capitalatlas.ai/funds/vertex-ventures-china) — Series A
- Shijie Investment (https://capitalatlas.ai/funds/shijie-investment) — Series A